About this trial
This single center, double blind, randomized controlled trial will evaluate whether adding intravenous diphenhydramine to a standard moderate sedation regimen improves pain control during first trimester procedural abortion. Participants undergoing uterine aspiration at less than 13 weeks gestation will be randomized 1 to 1 to receive standard moderate sedation with midazolam and fentanyl plus either diphenhydramine 50 mg intravenously or matching placebo. The primary outcome is participant reported pain during uterine aspiration measured by a 100 mm Visual Analog Scale.
Eligibility criteria
Qualifiers
Adults age 18 years and older
Desire procedural abortion with moderate sedation
Gestational age less than or equal to 13 weeks
Intrauterine pregnancy or pregnancy of unknown location
Disqualifiers
Desire medical abortion or desire to continue pregnancy
Gestational age greater than 13 weeks
Body mass index greater than 40
Age younger than 18 years
Trial design
Treatments tested in this trial
- Diphenhydramine
- Placebo